Robert S Kerbel
8PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 14, 2025
Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis.Kabir A Khan, Areeba A Qureshi, Ping Xu
|Apr 10, 2024
Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials.Hung-Yang Kuo, Kabir A Khan, Robert S Kerbel
|Aug 06, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.Xiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang
|Jun 14, 2021
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.Kabir A Khan, Florence Th Wu, William Cruz-Munoz
|Jul 21, 2020
Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers.Luana Schito, Sergio Rey, Ping Xu
|May 15, 2020
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis.Kabir A Khan, Robert S Kerbel
Pageof 2
Frequent Collaborators
4 joint publications
Kabir A Khan
2 joint publications
Hung-Yang Kuo
1 joint publications
Raquel Muñoz
1 joint publications
Luana Schito
1 joint publications
Florence Th Wu
1 joint publications
Sandhya Chipurupalli
1 joint publications
Kirill V Rosen
1 joint publications
Areeba A Qureshi
1 joint publications
Ping Xu
1 joint publications
Ton N Schumacher
